PL174170B1 - Preparat farmaceutyczny zawierający 3-podstawiony 2-oksindolo-1-karboksamid - Google Patents
Preparat farmaceutyczny zawierający 3-podstawiony 2-oksindolo-1-karboksamidInfo
- Publication number
- PL174170B1 PL174170B1 PL93308307A PL30830793A PL174170B1 PL 174170 B1 PL174170 B1 PL 174170B1 PL 93308307 A PL93308307 A PL 93308307A PL 30830793 A PL30830793 A PL 30830793A PL 174170 B1 PL174170 B1 PL 174170B1
- Authority
- PL
- Poland
- Prior art keywords
- weight
- formulation according
- propylene glycol
- preservative
- oil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95793092A | 1992-10-07 | 1992-10-07 | |
| PCT/US1993/008063 WO1994007488A1 (en) | 1992-10-07 | 1993-09-02 | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL308307A1 PL308307A1 (en) | 1995-07-24 |
| PL174170B1 true PL174170B1 (pl) | 1998-06-30 |
Family
ID=25500362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL93308307A PL174170B1 (pl) | 1992-10-07 | 1993-09-02 | Preparat farmaceutyczny zawierający 3-podstawiony 2-oksindolo-1-karboksamid |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0662831A1 (ko) |
| JP (1) | JP2721042B2 (ko) |
| KR (1) | KR950703338A (ko) |
| CN (1) | CN1089138A (ko) |
| AU (1) | AU676200B2 (ko) |
| BR (1) | BR9307182A (ko) |
| CA (1) | CA2146448A1 (ko) |
| CZ (1) | CZ282702B6 (ko) |
| EG (1) | EG20289A (ko) |
| FI (1) | FI934387A (ko) |
| HU (1) | HUT68533A (ko) |
| IL (1) | IL107122A (ko) |
| MX (1) | MX9306222A (ko) |
| MY (1) | MY109680A (ko) |
| NO (1) | NO951350L (ko) |
| NZ (1) | NZ256164A (ko) |
| PL (1) | PL174170B1 (ko) |
| RU (1) | RU2119353C1 (ko) |
| TW (1) | TW438798B (ko) |
| WO (1) | WO1994007488A1 (ko) |
| ZA (1) | ZA937405B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2076106B1 (es) * | 1993-08-26 | 1996-06-16 | Pfizer | Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas |
| AU2517095A (en) * | 1994-05-19 | 1995-12-18 | R.P. Scherer International Corporation | Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions |
| SK51296A3 (en) * | 1995-04-24 | 1997-04-09 | Pfizer | Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule |
| WO1998029136A1 (en) * | 1996-12-27 | 1998-07-09 | Takeda Chemical Industries, Ltd. | Stabilized tricyclic compound |
| JP5869764B2 (ja) * | 2011-01-07 | 2016-02-24 | 中日本カプセル 株式会社 | カプセル充填用組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
| US5008283A (en) * | 1990-03-19 | 1991-04-16 | Pfizer Inc. | Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| EP0620728B1 (en) * | 1992-01-13 | 1997-01-08 | Pfizer Inc. | Preparation of tablets of increased strength |
-
1993
- 1993-08-17 TW TW082106612A patent/TW438798B/zh active
- 1993-09-02 BR BR9307182A patent/BR9307182A/pt not_active Application Discontinuation
- 1993-09-02 AU AU48392/93A patent/AU676200B2/en not_active Ceased
- 1993-09-02 EP EP93921210A patent/EP0662831A1/en not_active Withdrawn
- 1993-09-02 RU RU95111378A patent/RU2119353C1/ru active
- 1993-09-02 JP JP6509043A patent/JP2721042B2/ja not_active Expired - Lifetime
- 1993-09-02 KR KR1019950701320A patent/KR950703338A/ko not_active Application Discontinuation
- 1993-09-02 CA CA002146448A patent/CA2146448A1/en not_active Abandoned
- 1993-09-02 PL PL93308307A patent/PL174170B1/pl unknown
- 1993-09-02 CZ CZ95878A patent/CZ282702B6/cs unknown
- 1993-09-02 NZ NZ256164A patent/NZ256164A/en unknown
- 1993-09-02 WO PCT/US1993/008063 patent/WO1994007488A1/en not_active Application Discontinuation
- 1993-09-27 IL IL10712293A patent/IL107122A/en not_active IP Right Cessation
- 1993-10-04 EG EG64393A patent/EG20289A/xx active
- 1993-10-05 MY MYPI93002026A patent/MY109680A/en unknown
- 1993-10-06 FI FI934387A patent/FI934387A/fi not_active Application Discontinuation
- 1993-10-06 ZA ZA937405A patent/ZA937405B/xx unknown
- 1993-10-06 CN CN93118904A patent/CN1089138A/zh active Pending
- 1993-10-06 MX MX9306222A patent/MX9306222A/es unknown
- 1993-10-06 HU HU9302821A patent/HUT68533A/hu unknown
-
1995
- 1995-04-06 NO NO951350A patent/NO951350L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0662831A1 (en) | 1995-07-19 |
| IL107122A (en) | 1998-08-16 |
| ZA937405B (en) | 1995-04-06 |
| HU9302821D0 (en) | 1993-12-28 |
| AU676200B2 (en) | 1997-03-06 |
| PL308307A1 (en) | 1995-07-24 |
| FI934387A0 (fi) | 1993-10-06 |
| MX9306222A (es) | 1994-04-29 |
| BR9307182A (pt) | 1999-03-30 |
| JP2721042B2 (ja) | 1998-03-04 |
| RU2119353C1 (ru) | 1998-09-27 |
| NO951350L (no) | 1995-06-06 |
| TW438798B (en) | 2001-06-07 |
| AU4839293A (en) | 1994-04-26 |
| CN1089138A (zh) | 1994-07-13 |
| NO951350D0 (no) | 1995-04-06 |
| CA2146448A1 (en) | 1994-04-14 |
| WO1994007488A1 (en) | 1994-04-14 |
| FI934387A (fi) | 1994-04-08 |
| IL107122A0 (en) | 1993-12-28 |
| CZ87895A3 (en) | 1995-10-18 |
| EG20289A (en) | 1998-07-30 |
| JPH07507809A (ja) | 1995-08-31 |
| MY109680A (en) | 1997-04-30 |
| CZ282702B6 (cs) | 1997-09-17 |
| HUT68533A (en) | 1995-04-27 |
| NZ256164A (en) | 1997-03-24 |
| KR950703338A (ko) | 1995-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6300377B1 (en) | Coenzyme Q products exhibiting high dissolution qualities | |
| CA2366793C (en) | Propofol formulation with enhanced microbial characteristics | |
| JP4209467B2 (ja) | 経口投与用製剤組成物 | |
| CA2082418A1 (en) | Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof | |
| CA2270254A1 (en) | Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators | |
| KR20050085037A (ko) | 변형 비히클을 갖는 약학 조성물 | |
| EP0152292A2 (en) | Acetaminophen gelatin capsules | |
| PL174170B1 (pl) | Preparat farmaceutyczny zawierający 3-podstawiony 2-oksindolo-1-karboksamid | |
| US5795902A (en) | 3-substituted 2-oxindole-1 carboxamide pharmaceutical compositions | |
| WO2014095628A1 (en) | Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa) | |
| KR100475388B1 (ko) | 1,2,4-벤조트리아진옥사이드의경구겔캡슐제제 | |
| EP0965340B1 (en) | Dermatologic preparation | |
| KR930000048B1 (ko) | 연질 캡슐용 폴리프레닐계 화합물 조성물 | |
| DE60101370T2 (de) | Pharmazeutische zusammensetzungen, die terbinafin enthalten | |
| BG103917A (bg) | Разтворими дозирани форми от сертралин включени вжелатинови капсули | |
| JP2001500145A (ja) | 局所的使用のための製剤 | |
| CN113262302B (zh) | 可注射长效半固体凝胶制剂 | |
| US4612310A (en) | Antirheumatically active suppositories | |
| JPH0390022A (ja) | 皮膚疾患治療用外用剤 | |
| JPH0368009B2 (ko) | ||
| EP0431659A1 (en) | Pharmaceutical compositions of tebufelone | |
| JP2024536494A (ja) | エコー源性組成物および疼痛の治療のためのその使用方法 | |
| EP0339176A1 (en) | Suppository containing a non-steroidal anti-inflammatory medicament | |
| WO2002009670A1 (en) | Liquid or semi-solid pharmaceutical excipient and pharmaceutical composition comprising the same | |
| JPH1077227A (ja) | ジクロフェナクナトリウム徐放性坐剤 |